Back to Top
Efungumab Biosimilar - Research Grade
$710.00 - $6,900.00
Efungumab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
heat shock protein 90 homolog [Candida albicans]
Concentration
5mg/ml
Isotype
scFv - heavy - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Shipping Conditions
Blue ice
Background
Candida albicans heat shock protein 90 (Hsp90) is a fungal chaperone antigen recognized in invasive candidiasis research and antifungal immunity studies. Our research-grade anti-Candida Hsp90 scFv is an unconjugated, non-therapeutic analog of efungumab, offered solely for research use only (RUO). Crafted to demanding in vivo standards, this ultra-pure, low-endotoxin preparation is available in scalable milligram (mg) to gram (g) quantities to serve heavy-usage, high-throughput laboratories. It acts as a dependable binding control and active reagent for in vitro antigen-recognition assays, fungal neutralization screens, and in vivo infection models, supporting antifungal biologics characterization.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review

















